Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 822,415 Less Arrow 597,542 Less Arrow 415,292
Financial expenses 35,909 More Arrow 46,283 More Arrow 55,693
Earnings before taxes 199,948 Less Arrow 94,521 Less Arrow 22,314
EBITDA 155,778 Less Arrow 64,097 Less Arrow 48,576
Total assets 2,402,743 Less Arrow 2,195,611 Less Arrow 1,733,084
Current assets 813,076 More Arrow 826,405 Less Arrow 467,508
Current liabilities 177,510 Less Arrow 134,488 More Arrow 134,896
Equity capital 2,156,778 Less Arrow 1,945,045 Less Arrow 1,430,136
- share capital 805 Equal arrow 805 Less Arrow 762
Employees (average) 158 Less Arrow 130 Less Arrow 114

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 89.8% Less Arrow 88.6% Less Arrow 82.5%
Turnover per employee 5,205 Less Arrow 4,596 Less Arrow 3,643
Profit as a percentage of turnover 24.3% Less Arrow 15.8% Less Arrow 5.4%
Return on assets (ROA) 9.8% Less Arrow 6.4% Less Arrow 4.5%
Current ratio 458.0% More Arrow 614.5% Less Arrow 346.6%
Return on equity (ROE) 9.3% Less Arrow 4.9% Less Arrow 1.6%
Change turnover 224,873 Less Arrow 182,250 Less Arrow 156,906
Change turnover % 38% More Arrow 44% More Arrow 61%
Chg. No. of employees 28 Less Arrow 16 More Arrow 22
Chg. No. of employees % 22% Less Arrow 14% More Arrow 24%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.